跳至主要内容
临床试验/CTRI/2021/11/038076
CTRI/2021/11/038076招募中3 期

Effect of Terlipressin in Patients Undergoing Major Hepatectomies for Liver Cancers: A Prospective Randomized Controlled Phase-III Trial (TerliHep Trial) - TerliHep

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients diagnosed with liver tumors
  • Expected resection of at least three liver segments OR posterior sectionectomy
  • Age above 18 years
  • ASA class I-III.

排除标准

  • Preoperative severe renal failure (estimated glomerular filtration rate < 30 ml/min)
  • Severe liver dysfunction (Child-Turcotte-Pugh grade C).
  • Uncontrolled hypertensive (Blood Pressure >180/90) patients on treatment.
  • Recent myocardial infarction (within 6 month), severe valvular heart disease.
  • Any history of intracranial bleeding.
  • Preoperative hyponatremia.

研究者

相似试验